High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study. 1986

M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter

Encouraging results have recently been reported for studies using folinic acid in combination with 5-fluorouracil (5-FU) in the treatment of patients with gastrointestinal (GI) malignancies. Thirty-six patients with advanced colorectal cancer with unequivocal evidence of progression while treated with fluoropyrimidines were treated with a six-day continuous infusion of 500 mg/m2/d of folinic acid initiated 24 hours before a five-day course of 5-FU administered as an intravenous (IV) bolus of 370 mg/m2/d. An initial dose of 250 mg/m2/d of 5-FU was used in patients previously treated with ionizing radiation and/or a nitrosourea. Three objective partial responses were observed. The overall median duration of survival was 8.1 months. Toxicity was acceptable and not in excess of that expected for 5-FU alone.

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
September 1988, European journal of cancer & clinical oncology,
M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
October 1995, Cancer,
M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
September 1995, British journal of cancer,
M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
March 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
January 2012, Asian Pacific journal of cancer prevention : APJCP,
M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
January 1993, European journal of cancer (Oxford, England : 1990),
M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
January 1988, Cancer investigation,
M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
January 1997, Anticancer research,
M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
May 1992, Cancer research,
M Bertrand, and J H Doroshow, and P Multhauf, and D W Blayney, and B I Carr, and G Cecchi, and D Goldberg, and L Leong, and K Margolin, and G Metter
September 1992, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!